NDC 70518-2447

Jardiance

Empagliflozin

Jardiance is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Empagliflozin.

Product ID70518-2447_9823e8e5-9c17-605b-e053-2a95a90a8c01
NDC70518-2447
Product TypeHuman Prescription Drug
Proprietary NameJardiance
Generic NameEmpagliflozin
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-11-22
Marketing CategoryNDA / NDA
Application NumberNDA204629
Labeler NameREMEDYREPACK INC.
Substance NameEMPAGLIFLOZIN
Active Ingredient Strength25 mg/1
Pharm ClassesSodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70518-2447-0

90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2447-0)
Marketing Start Date2019-11-22
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
EMPAGLIFLOZIN25 mg/1

Pharmacological Class

  • Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
  • Sodium-Glucose Transporter 2 Inhibitors [MoA]

NDC Crossover Matching brand name "Jardiance" or generic name "Empagliflozin"

NDCBrand NameGeneric Name
0597-0152JardianceEmpagliflozin
0597-0153JardianceEmpagliflozin
55154-0411JardianceEmpagliflozin
55154-0412JardianceEmpagliflozin
71610-177JardianceEmpagliflozin
70518-1986JardianceEmpagliflozin
50090-4384JardianceEmpagliflozin
50090-4492JardianceEmpagliflozin
70518-2447JardianceEmpagliflozin

© 2019 FDA.report
This site is not affiliated with or endorsed by the FDA.